Former FierceMedTech Fierce 15 winner Axonics Modulation Technologies has received FDA approval for its rechargeable neuromodulation implant to treat bowel dysfunction. According to the company, its r ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation ...

IRVINE, Calif. & KNOXVILLE, Tenn.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable ...

Among Largest Rural Health Systems in the U.S. “I appreciate the commitment Axonics has made to innovate in this space,” said Kevin Benson, M.D., a urogynecologist at Sanford Health who also served as ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Sacral Nerve Stimulation Market 2017-2021" report to their offering. The global sacral nerve stimulation market ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...

Medtronic (MDT) recently announced that it has received a favorable decision with respect to a long-standing patent dispute related to sacral neuromodulation. Specifically, per Medtronic’s press ...

Fewer punctures and shorter surgical time reported for sacral neuromodulation with 3D printing and ultrasound localization. (HealthDay News) — For patients with neurogenic bladder and pelvic ...

Follow-up of patients at a Belgian institution reveals that sacral neuromodulation (SNM) is effective for the treatment of lower urinary tract dysfunction (LUTD) over the long term, but often requires ...

A 26-year-old female who had been suffering from overactive painful bladder for the last 12 years receives advanced sacral neuromodulation to treat overactive painful bladder Post Graduate Institute ...

Axonics Inc. received FDA approval for its recharge-free sacral neuromodulation (SNM) implantable neurostimulator (INS) for bladder and bowel dysfunction. The F15’s primary cell requires no recharging ...

This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. Over 10 months, complete continence was achieved by approximately half of implanted patients. Real-world ...